Samil Pharmaceutical Co.,Ltd (000520.KS) KSC

9,340.00

+20(+0.21%)

Updated at January 14 03:19PM

Currency In KRW

Valuation

Market Cap236.48B
Enterprise Value381.42B
P/E Ratio-7.33
PEG Ratio0.21
Price/Sales Ratio0.92
Price/Book Ratio1.39
Enterprise/Revenue1.66
Enterprise/EBITDA17.21

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.13
Operating Margin-0.08

Management Effectiveness

Return On Assets-0.07
Return On Equity-0.17

Income Statement

Revenue219.7B
Revenue/Share10,120.98
Gross Profit80.91B
EBITDA8.66B
Net Income-5.63B
Diluted EPS-313

Balance Sheet

Total Cash6.49B
Total Cash/Share311.99
Total Debt164.45B
Total Debt/Equity1.15
Current Ratio0.61
Book Value Per Share6,734.59

Price History

52-Week Change-32.85
52-Week High14,730
52-Week Low9,120
Moving Average 50 Days10,112.6
Moving Average 200 Days10,591

Statistics

Average Volume345,398
Shares Outstanding21.23M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor11:10
Last Split DateMarch 24, 2023